KEAP1 and non-small cell lung carcinoma: For this effect to take place, it is necessary for cysteine dioxygenase 1 (CDO1), an enzyme that catalyzes the irreversible conversion of cysteine to cysteine sulfinic acid, to be silenced, as it happens in human non-small-cell lung cancers that harbor mutations in KEAP1.